ArticleBMC cancer2023

Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation.

Kang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.